Life Length Receives CMS Certification, EU Grant for Biomarker Study
Telomere diagnostics firm Life Length has received an estimated $3.5 million grant from the European Union under the Horizon 2020 program to support the company’s clinical studies on a potential biomarker for cancer treatment. The Telomere Analysis Technology cellular health biomarker works to identify the biological health of cells, measure the effects of lifestyle programs and detect the risk and early onset of […] More